Scarica l'app Stockscreener
7.10
16.39%
1.00
Dopo l'orario di chiusura:
7.09
-0.010
-0.14%
Precedente Chiudi:
$6.10
Aprire:
$6.05
Volume 24 ore:
3.99M
Relative Volume:
15.42
Capitalizzazione di mercato:
$197.03M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+36.80%
1M Prestazione:
+0.00%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$6.0001
$7.29
Intervallo di 1 settimana:
$5.18
$7.29
Portata 52W:
$4.68
$7.29
Curanex Pharmaceuticals Inc Stock (CURX) Company Profile
Nome
Curanex Pharmaceuticals Inc
Settore
Industria
Telefono
-
Indirizzo
-
Confronta CURX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CURX
Curanex Pharmaceuticals Inc
|
7.10 | 162.62M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Curanex Pharmaceuticals Inc Borsa (CURX) Ultime notizie
Chinese Stocks To Watch Today – August 31st - Defense World
Chinese Stocks To Watch TodayAugust 31st - MarketBeat
Promising Chinese Stocks To ConsiderAugust 30th - MarketBeat
Chinese Stocks To Research – August 29th - Defense World
Wall Street Zen Upgrades Curanex Pharmaceuticals (NASDAQ:CURX) to “Hold” - Defense World
Curanex Pharmaceuticals (NASDAQ:CURX) Raised to “Hold” at Wall Street Zen - Defense World
IPO NewsUS IPO Weekly Recap: Quiet week as IPO market gears up for a busy fall - renaissancecapital.com
Curanex Pharmaceuticals closes $15 million IPO on NASDAQ - Investing.com
Curanex Pharmaceuticals Inc. (CURX) Soars 10.52% on Successful IPO - AInvest
Curanex Pharmaceuticals shares rise 7.30% premarket after closing its initial public offering of 3,750,000 shares at $4.00 per share. - AInvest
Curanex Pharmaceuticals Inc. Announces Closing of its Initial Public Offering - GlobeNewswire
Curanex Pharmaceuticals' IPO: A Strategic Bet on Botanical Innovation in a Resilient Biotech Sector - AInvest
Curanex Pharmaceuticals closes $15 million IPO on NASDAQ By Investing.com - Investing.com Canada
Curanex Pharmaceuticals Inc. announces closing of its initial public offering - MarketScreener
Curanex Pharmaceuticals Completes Initial Public Offering for $15 Million - AInvest
$15 Million IPO: Inflammatory Disease Biotech Curanex Launches on Nasdaq with Botanical Drug Focus - Stock Titan
Curanex Pharmaceuticals Inc(NasdaqCM: CURX) added to NASDAQ Composite Index - MarketScreener
Curanex Pharmaceuticals announces pricing of its initial public offering - MSN
IPO Preview | Curanex Will be Listed on 8/26/2025 - AInvest
Curanex Pharmaceuticals prices IPO at $4 per share - Investing.com
Curanex Pharmaceuticals prices IPO at $4 per share, raises $15 million By Investing.com - Investing.com South Africa
Curanex Pharmaceuticals' Nasdaq Debut: A Cautious Bet on Botanical Innovation - AInvest
Curanex Pharmaceuticals Shares Fall in Nasdaq Debut - MarketScreener
CURX IPO NewsPreclinical biotech Curanex Pharmaceuticals prices IPO at $4, the low end of the range - renaissancecapital.com
Curanex Pharmaceuticals prices IPO at $4 per share, raises $15 million - Investing.com
Curanex Pharmaceuticals prices IPO at $4 per share By Investing.com - Investing.com UK
Curanex pharmaceuticals announces pricing of its initial public offering - MarketScreener
Curanex Pharmaceuticals announces pricing of IPO - AInvest
$15 Million IPO: Botanical Drug Developer Curanex Lists on Nasdaq to Advance Ulcerative Colitis Treatment - Stock Titan
Curanex Pharmaceuticals Plans $10 million IPO for August 26th (CURX) - Defense World
Curanex Pharmaceuticals Files for 3.75M Share IPO at $4-$6/sh - Investing.com Canada
Curanex, botanical drug developer, files for $10M IPO - MSN
Curanex Pharmaceuticals Inc Azioni (CURX) Dati Finanziari
Non sono disponibili dati finanziari per Curanex Pharmaceuticals Inc (CURX). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):